← Back to Clinical Trials
Recruiting NCT06687122

NCT06687122 Egg Intake, Metabolic Outcomes and Choline Levels

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06687122
Status Recruiting
Phase
Sponsor University of Guelph
Condition Obesity and Obesity-related Medical Conditions
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2025-01-24
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 30 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
3 whole eggs

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2025-01-24 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this research is to determine the effect of additional daily egg intake on metabolic phenotypes and metabolism in the context of obesity.

Eligibility Criteria

Inclusion Criteria: * Male or female participant of any race or ethnicity between 30-65 (inclusive) years of age * BMI \> 30 kg/m2 * Non-smoker * Willing to consume 3 eggs per day for one dietary period of 4 weeks * Willing to avoid eggs during the rest of the study except for eggs that are provided * Willing to follow the study protocol including maintaining usual lifestyle during the entire study Exclusion Criteria: * Age \< 30 or \> 65 years * BMI \< 30 kg/m2 * Vegans or individuals who do not consume eggs * Individuals who are currently pregnant or planning to become pregnant during the course of the study; or are currently breastfeeding * Smokers, users of recreational drugs * Individuals taking antibiotics or natural health products including prebiotics or probiotics

Contact & Investigator

Central Contact

Clara E. Cho, PhD

✉ claracho@uoguelph.ca

📞 (519) 824-4120

Frequently Asked Questions

Who can join the NCT06687122 clinical trial?

This trial is open to participants of all sexes, aged 30 Years or older, up to 65 Years, studying Obesity and Obesity-related Medical Conditions. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06687122 currently recruiting?

Yes, NCT06687122 is actively recruiting participants. Contact the research team at claracho@uoguelph.ca for enrollment information.

Where is the NCT06687122 trial being conducted?

This trial is being conducted at Québec, Canada.

Who is sponsoring the NCT06687122 clinical trial?

NCT06687122 is sponsored by University of Guelph. The trial plans to enroll 20 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology